BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28653753)

  • 21. Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis.
    Samaan MA; Shen B; Mosli MH; Zou G; Sandborn WJ; Shackelton LM; Nelson S; Stitt L; Bloom S; Pardi DS; Gionchetti P; Lindsay J; Travis S; Hart A; Silverberg MS; Feagan BG; D'Haens GR; Jairath V
    Gastrointest Endosc; 2018 Aug; 88(2):360-369.e2. PubMed ID: 29660321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Magnetic Resonance Imaging Index to Predict Crohn's Disease Postoperative Recurrence: The MONITOR Index.
    Schaefer M; Laurent V; Grandmougin A; Vuitton L; Bourreille A; Luc A; Clerc-Urmes I; Orry X; Frampas E; De Billy M; Pouillon L; Le Berre C; Gay C; Meyer J; Baumann C; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2022 May; 20(5):e1040-e1049. PubMed ID: 34216820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability of histologic assessment in patients with eosinophilic oesophagitis.
    Warners MJ; Ambarus CA; Bredenoord AJ; Verheij J; Lauwers GY; Walsh JC; Katzka DA; Nelson S; van Viegen T; Furuta GT; Gupta SK; Stitt L; Zou G; Parker CE; Shackelton LM; D Haens GR; Sandborn WJ; Dellon ES; Feagan BG; Collins MH; Jairath V; Pai RK
    Aliment Pharmacol Ther; 2018 Apr; 47(7):940-950. PubMed ID: 29460418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease.
    Pariente B; Mary JY; Danese S; Chowers Y; De Cruz P; D'Haens G; Loftus EV; Louis E; Panés J; Schölmerich J; Schreiber S; Vecchi M; Branche J; Bruining D; Fiorino G; Herzog M; Kamm MA; Klein A; Lewin M; Meunier P; Ordas I; Strauch U; Tontini GE; Zagdanski AM; Bonifacio C; Rimola J; Nachury M; Leroy C; Sandborn W; Colombel JF; Cosnes J
    Gastroenterology; 2015 Jan; 148(1):52-63.e3. PubMed ID: 25241327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Which magnetic resonance imaging feature is associated with treatment response in perianal fistulizing Crohn's disease?
    Richard N; Derinck A; Bridoux V; Charpentier C; Savoye Collet C; Savoye G
    Abdom Radiol (NY); 2024 Mar; ():. PubMed ID: 38512515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI characteristics of proctitis in Crohn's disease on perianal MRI.
    Tutein Nolthenius CJ; Bipat S; Mearadji B; Spijkerboer AM; Ponsioen CY; Montauban van Swijndregt AD; Stoker J
    Abdom Radiol (NY); 2016 Oct; 41(10):1918-30. PubMed ID: 27315072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging and Crohn's disease endoscopic index of severity: Correlations and concordance.
    Zhu NY; Zhao XS; Miao F
    World J Gastroenterol; 2018 Jun; 24(21):2279-2290. PubMed ID: 29881237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bowel Damage in Crohn's Disease: Direct Comparison of Ultrasonography-based and Magnetic Resonance-based Lemann Index.
    Rispo A; Imperatore N; Testa A; Mainenti P; De Palma GD; Luglio G; Maurea S; Nardone OM; Caporaso N; Castiglione F
    Inflamm Bowel Dis; 2017 Jan; 23(1):143-151. PubMed ID: 27930407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of an MRI-based score of disease activity in perianal fistulizing Crohn's disease.
    Horsthuis K; Ziech ML; Bipat S; Spijkerboer AM; de Bruine-Dobben AC; Hommes DW; Stoker J
    Clin Imaging; 2011; 35(5):360-5. PubMed ID: 21872125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expert Consensus on Optimal Acquisition and Development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: A Reliability and Inter-rater Variability Study on Intestinal Ultrasonography in Crohn's Disease.
    Novak KL; Nylund K; Maaser C; Petersen F; Kucharzik T; Lu C; Allocca M; Maconi G; de Voogd F; Christensen B; Vaughan R; Palmela C; Carter D; Wilkens R
    J Crohns Colitis; 2021 Apr; 15(4):609-616. PubMed ID: 33098642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Grading luminal Crohn's disease: which MRI features are considered as important?
    Ziech ML; Bossuyt PM; Laghi A; Lauenstein TC; Taylor SA; Stoker J
    Eur J Radiol; 2012 Apr; 81(4):e467-72. PubMed ID: 21684703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.
    Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L
    BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining and predicting deep remission in patients with perianal fistulizing Crohn's disease on anti-tumor necrosis factor therapy.
    Papamichael K; Cheifetz AS
    World J Gastroenterol; 2017 Sep; 23(34):6197-6200. PubMed ID: 28974885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity.
    Rimola J; Ordás I; Rodriguez S; García-Bosch O; Aceituno M; Llach J; Ayuso C; Ricart E; Panés J
    Inflamm Bowel Dis; 2011 Aug; 17(8):1759-68. PubMed ID: 21744431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI features of perianal fistulas: is there a difference between Crohn's and non-Crohn's patients?
    Oliveira IS; Kilcoyne A; Price MC; Harisinghani M
    Abdom Radiol (NY); 2017 Apr; 42(4):1162-1168. PubMed ID: 27885389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-Dimensional Modeling for Crohn's Fistula-in-Ano: A Novel, Interactive Approach.
    Lam D; Yong E; D'Souza B; Woods R
    Dis Colon Rectum; 2018 May; 61(5):567-572. PubMed ID: 29624551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Grading Crohn disease activity with MRI: interobserver variability of MRI features, MRI scoring of severity, and correlation with Crohn disease endoscopic index of severity.
    Tielbeek JA; Makanyanga JC; Bipat S; Pendsé DA; Nio CY; Vos FM; Taylor SA; Stoker J
    AJR Am J Roentgenol; 2013 Dec; 201(6):1220-8. PubMed ID: 24261360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence.
    Baillet P; Cadiot G; Goutte M; Goutorbe F; Brixi H; Hoeffel C; Allimant C; Reymond M; Obritin-Guilhen H; Magnin B; Bommelaer G; Pereira B; Hordonneau C; Buisson A
    World J Gastroenterol; 2018 Feb; 24(5):641-650. PubMed ID: 29434453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of three magnetic resonance enterography indices for grading activity in Crohn's disease.
    Rimola J; Alvarez-Cofiño A; Pérez-Jeldres T; Ayuso C; Alfaro I; Rodríguez S; Ricart E; Ordás I; Panés J
    J Gastroenterol; 2017 May; 52(5):585-593. PubMed ID: 27599973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the extension and the inflammatory activity in Crohn's disease: comparison of ultrasound and MRI.
    Martínez MJ; Ripollés T; Paredes JM; Blanc E; Martí-Bonmatí L
    Abdom Imaging; 2009; 34(2):141-8. PubMed ID: 18214582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.